NCT07395258 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07395258
Title	A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Recruitment	Suspended
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Boehringer Ingelheim
Indications	Advanced Solid Tumor
Therapies	BI 3923948 BI 3923948 + Ezabenlimab
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Yale New Haven Hospital		New Haven	Connecticut	06511	United States	Details
University of Minnesota		Minneapolis	Minnesota	55455	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07395258Clinical Trial Detail